Correlation Between Sabra Health and National Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sabra Health and National Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sabra Health and National Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sabra Health Care and National Health Investors, you can compare the effects of market volatilities on Sabra Health and National Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sabra Health with a short position of National Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sabra Health and National Health.

Diversification Opportunities for Sabra Health and National Health

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Sabra and National is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Sabra Health Care and National Health Investors in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on National Health Investors and Sabra Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sabra Health Care are associated (or correlated) with National Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of National Health Investors has no effect on the direction of Sabra Health i.e., Sabra Health and National Health go up and down completely randomly.

Pair Corralation between Sabra Health and National Health

Assuming the 90 days horizon Sabra Health is expected to generate 4.69 times less return on investment than National Health. In addition to that, Sabra Health is 1.2 times more volatile than National Health Investors. It trades about 0.03 of its total potential returns per unit of risk. National Health Investors is currently generating about 0.15 per unit of volatility. If you would invest  5,560  in National Health Investors on February 21, 2024 and sell it today you would earn a total of  440.00  from holding National Health Investors or generate 7.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Sabra Health Care  vs.  National Health Investors

 Performance 
       Timeline  
Sabra Health Care 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Sabra Health Care are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Sabra Health may actually be approaching a critical reversion point that can send shares even higher in June 2024.
National Health Investors 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in National Health Investors are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, National Health reported solid returns over the last few months and may actually be approaching a breakup point.

Sabra Health and National Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sabra Health and National Health

The main advantage of trading using opposite Sabra Health and National Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sabra Health position performs unexpectedly, National Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in National Health will offset losses from the drop in National Health's long position.
The idea behind Sabra Health Care and National Health Investors pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance